Immunology, Transplantation and Infectious diseases

Hepatotropic viruses related diseases


Senior physician

Caterina Uberti-Foppa


The general mission of the unit is to translate new biologic knowledge on hepatotropic viruses from the bench to the bedside. To do this, the laboratory and clinical team strictly works on the molecular basis of hepatitis B, C and chronic liver diseases.

Research activity

The main end point is to offer a better management of hepatitis virus related diseases from acute to chronic course, a tailored treatment, new non-invasive methods and algorithms for establishing liver fibrosis. The clinical research activity is also focused on the conduction of multicentric, international phase II and phase III clinical trials involving new molecules for the treatment of HBV and HCV infection, particularly in special populations such as HIV infected patients and in liver transplanted individuals.